CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Lacosamide

拉考沙胺 杂质对照品Lacosamide Impurities

EP58 个杂质条目58 impurity entries

本页汇总 拉考沙胺 的 58 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 58 impurity reference standards of Lacosamide with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 拉考沙胺(Lacosamide)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesStability-indicating normal-phase HPLC method development for separation and quantitative estimation of S-enantiomer of lacosamide in pharmaceutical drug substance and tablet dosage form
    Biomedical chromatography : BMC · 2023 · Vadagam N et al.  ·  PMID 37325866  ·  DOI
  2. 杂质研究Impurity studiesIdentification and characterization of stress degradants of lacosamide by LC-MS and ESI-Q-TOF-MS/MS: development and validation of a stability indicating RP-HPLC method
    Journal of pharmaceutical and biomedical analysis · 2014 · Ramisetti NR et al.  ·  PMID 24699370  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and Validation of Stability-Indicating High-Performance Liquid Chromatography Method for Estimation of Lacosamide in Bulk and Its Pharmaceutical Dosage Form
    Journal of chromatographic science · 2023 · Padhiyar S et al.  ·  PMID 36465018  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of Antiepileptic Drug (R)-Lacosamide and Chronic Pain Reliever (S)-Lacosamide from Chiral Glycine Enolate Equivalent
    The Journal of organic chemistry · 2023 · Bhamboo P et al.  ·  PMID 37171159  ·  DOI
  • 合成方法SynthesisAn enantioselective approach to functionalized amino acids: total synthesis of antiepileptic drug (R)-lacosamide
    The Journal of organic chemistry · 2015 · Garg Y, Pandey SK  ·  PMID 25798932  ·  DOI

拉考沙胺 —— 原料药与杂质对照品Lacosamide — drug substance & impurities

共 59 个条目(含原料药本体)59 items incl. the drug substance
Lacosamide structure
EP原料药 APIAPI
拉考沙胺Lacosamide
Lacosamide
CAS No.175481-36-4
Chemical FormulaC13H18N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 1(Lacosamide EP Impurity A) structure
EPA
拉考沙胺杂质1(拉考沙胺EP杂质A)Lacosamide Impurity 1(Lacosamide EP Impurity A)
Lacosamide Impurity 1(Lacosamide EP Impurity A)
CAS No.175481-37-5
Chemical FormulaC13H18N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 1-d3 (Lacosamide EP Impurity A) structure
EPA
拉考沙胺杂质1-d3 (拉考沙胺EP杂质A-d3)Lacosamide Impurity 1-d3 (Lacosamide EP Impurity A)
Lacosamide Impurity 1-d3 (Lacosamide EP Impurity A)
CAS No.1795786-76-3
Chemical FormulaC13H15D3N2O3
Purity>95%询价On request
Lacosamide Impurity 43 (Lacosamide EP Impurity B) structure
EPB
拉考沙胺杂质43 (拉考沙胺EP杂质B)Lacosamide Impurity 43 (Lacosamide EP Impurity B)
Lacosamide Impurity 43 (Lacosamide EP Impurity B)
CAS No.1822463-67-1
Chemical FormulaC14H18N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 40 (Lacosamide EP Impurity D Oxalate) structure
EPD
拉考沙胺杂质40 (拉考沙胺EP杂质D 草酸盐)Lacosamide Impurity 40 (Lacosamide EP Impurity D Oxalate)
Lacosamide Impurity 40 (Lacosamide EP Impurity D Oxalate)
CAS No.1379592-19-4
Chemical FormulaC11H16N2O2·C2H2O4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 40 Hydrochloride (Lacosamide EP Impurity D Hydrochloride) structure
EPD
拉考沙胺杂质40 盐酸盐 (拉考沙胺EP杂质D 盐酸盐)Lacosamide Impurity 40 Hydrochloride (Lacosamide EP Impurity D Hydrochloride)
Lacosamide Impurity 40 Hydrochloride (Lacosamide EP Impurity D Hydrochloride)
CAS No.2041100-16-5
Chemical FormulaC11H16N2O2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 40 Monomer (Lacosamide EP Impurity D ) structure
EPD
拉考沙胺杂质40 单体 (拉考沙胺EP杂质D)Lacosamide Impurity 40 Monomer (Lacosamide EP Impurity D )
Lacosamide Impurity 40 Monomer (Lacosamide EP Impurity D )
CAS No.262845-82-9
Chemical FormulaC11H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 41(Lacosamide EP Impurity E) structure
EPE
拉考沙胺杂质41 (拉考沙胺EP杂质E)Lacosamide Impurity 41(Lacosamide EP Impurity E)
Lacosamide Impurity 41(Lacosamide EP Impurity E)
CAS No.374088-96-7
Chemical FormulaC10H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 42 (Lacosamide EP Impurity F) structure
EPF
拉考沙胺杂质42 (拉考沙胺EP杂质F)Lacosamide Impurity 42 (Lacosamide EP Impurity F)
Lacosamide Impurity 42 (Lacosamide EP Impurity F)
CAS No.171623-02-2
Chemical FormulaC12H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 6 (Lacosamide EP Impurity F) (R-Isomer) structure
EPF
拉考沙胺杂质6 (拉考沙胺EP杂质F) (R-异构体)Lacosamide Impurity 6 (Lacosamide EP Impurity F) (R-Isomer)
Lacosamide Impurity 6 (Lacosamide EP Impurity F) (R-Isomer)
CAS No.175481-38-6
Chemical FormulaC12H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 7 (Lacosamide EP Impurity G) structure
EPG
拉考沙胺杂质7 (拉考沙胺EP杂质G)Lacosamide Impurity 7 (Lacosamide EP Impurity G)
Lacosamide Impurity 7 (Lacosamide EP Impurity G)
CAS No.588-46-5
Chemical FormulaC9H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 83(N-Nitroso Lacosamide EP Impurity J) structure
EPJ
拉考沙胺杂质83(N-亚硝基拉考沙胺EP杂质J)Lacosamide Impurity 83(N-Nitroso Lacosamide EP Impurity J)
Lacosamide Impurity 83(N-Nitroso Lacosamide EP Impurity J)
CAS No.84375-85-9
Chemical FormulaC7H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 11 (Lacosamide EP Impurity K) structure
EPK
拉考沙胺杂质11 (拉考沙胺EP杂质K)Lacosamide Impurity 11 (Lacosamide EP Impurity K)
Lacosamide Impurity 11 (Lacosamide EP Impurity K)
CAS No.86921-49-5
Chemical FormulaC12H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Benzyltrimethylammonium hydroxide solution structure
—
苄基三甲基氢氧化铵 溶液Benzyltrimethylammonium hydroxide solution
Benzyltrimethylammonium hydroxide solution
CAS No.100-85-6
Chemical FormulaC10H17NO
Purity>95%现货In stock
10mg25mg50mg100mg
Lacosamide Impurity 2 structure
2
拉考沙胺杂质2Lacosamide Impurity 2
Lacosamide Impurity 2
CAS No.1318777-54-6
Chemical FormulaC14H18N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 3 structure
3
拉考沙胺杂质3Lacosamide Impurity 3
Lacosamide Impurity 3
CAS No.2742962-60-1
Chemical FormulaC14H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 4 structure
4
拉考沙胺杂质4Lacosamide Impurity 4
Lacosamide Impurity 4
CAS No.196601-69-1
Chemical FormulaC11H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 5 Hydrochloride structure
5
拉考沙胺杂质5 盐酸盐Lacosamide Impurity 5 Hydrochloride
Lacosamide Impurity 5 Hydrochloride
CAS No.1322062-75-8
Chemical FormulaC10H14N2O2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 5 structure
5
拉考沙胺杂质5Lacosamide Impurity 5
Lacosamide Impurity 5
CAS No.175481-39-7
Chemical FormulaC10H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 9 structure
9
拉考沙胺杂质9Lacosamide Impurity 9
Lacosamide Impurity 9
CAS No.2295925-90-3
Chemical FormulaC19H23N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 15 structure
15
拉考沙胺杂质15Lacosamide Impurity 15
Lacosamide Impurity 15
CAS No.175481-31-9
Chemical FormulaC10H14N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 17 structure
17
拉考沙胺杂质17Lacosamide Impurity 17
Lacosamide Impurity 17
CAS No.2295925-91-4
Chemical FormulaC17H26N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 18 structure
18
拉考沙胺杂质18Lacosamide Impurity 18
Lacosamide Impurity 18
CAS No.1253790-58-7
Chemical FormulaC15H22N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 21 structure
21
拉考沙胺杂质21Lacosamide Impurity 21
Lacosamide Impurity 21
CAS No.69805-82-9
Chemical FormulaC12H17NO2
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 22 structure
22
拉考沙胺杂质22Lacosamide Impurity 22
Lacosamide Impurity 22
CAS No.2295925-92-5
Chemical FormulaC12H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 24 structure
24
拉考沙胺杂质24Lacosamide Impurity 24
Lacosamide Impurity 24
CAS No.1454306-54-7
Chemical FormulaC13H18N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 25 structure
25
拉考沙胺杂质25Lacosamide Impurity 25
Lacosamide Impurity 25
CAS No.1454306-52-5
Chemical FormulaC13H18N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 28 structure
28
拉考沙胺杂质28Lacosamide Impurity 28
Lacosamide Impurity 28
CAS No.196601-67-9
Chemical FormulaC6H11NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 29 structure
29
拉考沙胺杂质29Lacosamide Impurity 29
Lacosamide Impurity 29
CAS No.93782-09-3
Chemical FormulaC12H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 33 structure
33
拉考沙胺杂质33Lacosamide Impurity 33
Lacosamide Impurity 33
CAS No.1375090-19-9
Chemical FormulaC17H25N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 34 structure
34
拉考沙胺杂质34Lacosamide Impurity 34
Lacosamide Impurity 34
CAS No.862372-15-4
Chemical FormulaC10H19NO5
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 35 structure
35
拉考沙胺杂质35Lacosamide Impurity 35
Lacosamide Impurity 35
CAS No.1318777-56-8
Chemical FormulaC14H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 39 structure
39
拉考沙胺杂质39Lacosamide Impurity 39
Lacosamide Impurity 39
CAS No.175481-26-2
Chemical FormulaC13H18N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 47 structure
47
拉考沙胺杂质47Lacosamide Impurity 47
Lacosamide Impurity 47
CAS No.1695551-74-6
Chemical FormulaC13H18N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 49 structure
49
拉考沙胺杂质49Lacosamide Impurity 49
Lacosamide Impurity 49
CAS No.1600503-99-8
Chemical FormulaC10H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 50 structure
50
拉考沙胺杂质50Lacosamide Impurity 50
Lacosamide Impurity 50
CAS No.474534-78-6
Chemical FormulaC11H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 51 structure
51
拉考沙胺杂质51Lacosamide Impurity 51
Lacosamide Impurity 51
CAS No.1808955-30-7
Chemical FormulaC17H26N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 56 structure
56
拉考沙胺杂质56Lacosamide Impurity 56
Lacosamide Impurity 56
CAS No.880468-89-3
Chemical FormulaC16H24N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 57 structure
57
拉考沙胺杂质57Lacosamide Impurity 57
Lacosamide Impurity 57
CAS No.56-93-9
Chemical FormulaC10H16N+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 58 Bromide structure
58
拉考沙胺杂质58 溴化物Lacosamide Impurity 58 Bromide
Lacosamide Impurity 58 Bromide
CAS No.5197-95-5
Chemical FormulaC13H22N+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 58 structure
58
拉考沙胺杂质58Lacosamide Impurity 58
Lacosamide Impurity 58
CAS No.56-37-1
Chemical FormulaC13H22N+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 59 structure
59
拉考沙胺杂质59Lacosamide Impurity 59
Lacosamide Impurity 59
CAS No.171623-03-3
Chemical FormulaC12H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 60 structure
60
拉考沙胺杂质60Lacosamide Impurity 60
Lacosamide Impurity 60
CAS No.1932811-49-8
Chemical FormulaC13H23NO7
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 61 structure
61
拉考沙胺杂质61Lacosamide Impurity 61
Lacosamide Impurity 61
CAS No.98632-99-6
Chemical FormulaC6H11NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 62 structure
62
拉考沙胺杂质62Lacosamide Impurity 62
Lacosamide Impurity 62
CAS No.65022-11-9
Chemical FormulaC6H11NO4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 63 structure
63
拉考沙胺杂质63Lacosamide Impurity 63
Lacosamide Impurity 63
CAS No.1629130-53-5
Chemical FormulaC17H26N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 64 structure
64
拉考沙胺杂质64Lacosamide Impurity 64
Lacosamide Impurity 64
CAS No.620-40-6
Chemical FormulaC21H21N
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 65 structure
65
拉考沙胺杂质65Lacosamide Impurity 65
Lacosamide Impurity 65
CAS No.388619-64-5
Chemical FormulaC14H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 66 structure
66
拉考沙胺杂质66Lacosamide Impurity 66
Lacosamide Impurity 66
CAS No.201938-49-0
Chemical FormulaC15H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 67 structure
67
拉考沙胺杂质67Lacosamide Impurity 67
Lacosamide Impurity 67
CAS No.1325220-60-7
Chemical FormulaC16H24N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 68 structure
68
拉考沙胺杂质68Lacosamide Impurity 68
Lacosamide Impurity 68
CAS No.51293-47-1
Chemical FormulaC9H17NO5
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 79 structure
79
拉考沙胺杂质79Lacosamide Impurity 79
Lacosamide Impurity 79
CAS No.2837780-56-8
Chemical FormulaC14H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 80 structure
80
拉考沙胺杂质80Lacosamide Impurity 80
Lacosamide Impurity 80
CAS No.1253790-25-8
Chemical FormulaC16H24N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 81 (N-Nitroso Lacosamide Impurity 86) structure
81
拉考沙胺杂质81 (N-亚硝基拉考沙胺杂质86)Lacosamide Impurity 81 (N-Nitroso Lacosamide Impurity 86)
Lacosamide Impurity 81 (N-Nitroso Lacosamide Impurity 86)
CAS No.28571-11-1
Chemical FormulaC7H8N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 81 Sodium Salt (N-Nitroso Lacosamide Impurity 86 Sodium Salt ) structure
81
拉考沙胺杂质81 钠盐 (N-亚硝基拉考沙胺杂质86 钠盐)Lacosamide Impurity 81 Sodium Salt (N-Nitroso Lacosamide Impurity 86 Sodium Salt )
Lacosamide Impurity 81 Sodium Salt (N-Nitroso Lacosamide Impurity 86 Sodium Salt )
CAS No.85166-50-3
Chemical FormulaC7H7N2O2-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 82 structure
82
拉考沙胺杂质82Lacosamide Impurity 82
Lacosamide Impurity 82
CAS No.57786-22-8
Chemical FormulaC10H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 86 structure
86
拉考沙胺杂质86Lacosamide Impurity 86
Lacosamide Impurity 86
CAS No.622-30-0
Chemical FormulaC7H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 89 structure
89
拉考沙胺杂质89Lacosamide Impurity 89
Lacosamide Impurity 89
CAS No.1323087-06-4
Chemical FormulaC13H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity 91 structure
91
拉考沙胺杂质91Lacosamide Impurity 91
Lacosamide Impurity 91
CAS No.6345-08-0
Chemical FormulaC9H9NO3
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

拉考沙胺 —— 研究文献与合成路线Lacosamide — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 拉考沙胺 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Lacosamide. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Identification and characterization of stress degradants of lacosamide by LC-MS and ESI-Q-TOF-MS/MS: development and validation of a stability indicating RP-HPLC method
    Ramisetti NR, Kuntamukkala R, Lakshetti S, et al. · Journal of pharmaceutical and biomedical analysis · 2014 · 被引 9cited 9
  2. PROCESSES FOR REDUCING IMPURITIES IN LACOSAMIDE
    SRIRAM HARI MOHAN, MADHRA MUKESH KUMAR, SHARMA MUKESH KUMAR · 2011
  3. Stability-indicating normal-phase HPLC method development for separation and quantitative estimation of S-enantiomer of lacosamide in pharmaceutical drug substance and tablet dosage form
    Vadagam N, Haridasyam SB, Venkatanarayana M · Biomedical chromatography : BMC · 2023 · 被引 2cited 2
  4. Development and Validation of Stability-Indicating High-Performance Liquid Chromatography Method for Estimation of Lacosamide in Bulk and Its Pharmaceutical Dosage Form
    Padhiyar S, Jivani KM, Upadhyay J, et al. · Journal of chromatographic science · 2023 · 被引 1cited 1
  5. Development and Validation of a Capillary Zone Electrophoresis Method for the Determination of Lacosamide in Pharmaceutical Dosage Forms Using Box-Behnken Experimental Design
    Güleç K, Ak D · Journal of AOAC International · 2026

合成与制备工艺专利Synthesis & process patents

  1. Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide
    WISDOM RICHARD, JUNG JOERG, MEUDT ANDREAS · 公开号 US2011319649US2011319649 · 2011
  2. Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide
    WISDOM RICHARD, JUNG JOERG, MEUDT ANDREAS · 公开号 EP2399901EP2399901 · 2011
  3. A PROCESS FOR THE PREPARATION OF LACOSAMIDE
    MUDDASANI PULLA REDDY, MADALAPU VEERABABU, NANNAPANENI VENKAIAH CHOWDARY · 公开号 WO2011095995WO2011095995 · 2011
  4. PROCESS FOR THE SYNTHESIS OF LACOSAMIDE
    BOLOGNA ALBERTO, CASTOLDI PATRIZIA, VERGANI DOMENICO, BERTOLINI GIORGIO · 公开号 WO2011092559WO2011092559 · 2011
  5. AN IMPROVED PROCESS FOR THE PREPARATION OF LACOSAMIDE
    PATEL MEHULKUMAR MAHESHBHAI, MOHITE VISHAL DILIPRAO, KHAMBAMPATI SUDHAKAR, CHITTURI TRINADHA RAO, et al. · 公开号 WO2012001710WO2012001710 · 2012

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

拉考沙胺 杂质谱研究要点Lacosamide — impurity profiling notes

下面这些是拿到 拉考沙胺 的 59 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 59 impurity entries for Lacosamide, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances